Sion Wyn

Conformity Ltd.
Director
Sion Wyn, Director, Conformity Ltd., is an acknowledged expert in computer system validation and compliance, data integrity, electronic records and signatures, and international regulations in this field. He assisted the FDA as a consultant with its re-examination of 21 CFR Part 11 and was a member of the core team that produced the FDA Guidance on 21 CFR Part 11 Scope and Application. He received the FDA Group Recognition Award for work on Part 11. Wyn was co-lead of the GAMP5 Guide - A Risk-Based Approach to Compliant GxP Computerized Systems, Second Edition, and the ISPE GAMP Guide - Record and Data Integrity, and is a member of the ISPE GAMP Global Steering Committee, and GAMP Editorial Board. Wyn received the 2006 ISPE Professional Achievement Award, which honours an ISPE Member who has made a significant contribution to the pharmaceutical industry. He received the ISPE UK Fellow Award in 2016.

Related Articles

GAMP® 5 Second Edition is Here!
iSpeak Blog
GAMP® 5 Second Edition is Here!

GAMP® 5 Second Edition is here! Since its publication, GAMP® 5 has been far and away the leading international guidance on GxP computerized systems validation and compliance, and it was time to update our guidance to...

IT Services: Applying Good IT Practice & Automation
Features
IT Services: Applying Good IT Practice & Automation

This article focuses on pragmatic quality- and risk-based approaches to IT infrastructure. It covers recommendations made by a US FDA/industry team linked to the US FDA Center for Devices and Radiological Health (CDRH) Case for Quality initiativeUS Food and Drug Administration Center for Devices and Radiological Health. “Case for Quality.” 29 July 2020.

A Gamp® Approach to Robotic Process Automation
Features
A GAMP® Approach to Robotic Process Automation

This article introduces the concept of robotic process automation (RPA) and discusses how the technology may be used within a GAMP® framework to support both non-GxP and GxP processes.